• Mashup Score: 5
    Economic Issues in Heart Failure in the United States - 2 year(s) ago

    Despite remarkable recent advances in the treatment of heart failure, the high cost of care limits delivery of effective care. The Heart Failure Society of America (HFSA) recognizes the important role of cost, cost-effectiveness, and value of diagnosis and treatment in caring for patients with heart failure. This review sponsored by HFSA describes the economic burden of heart failure, providing a…

    Source: Journal of Cardiac Failure
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of DLBHATTMD
      DLBHATTMD

      High cost of treating #heartfailure, with the largest chunk due to #hospitalizations. Great work by @paheidenreich @gcfmd @haiderwarraich and @HFSA colleagues: Economic Issues in Heart Failure in the United States https://t.co/H3ra9E1SHM #CardioTwitter #Cardiology

  • Mashup Score: 0
    Can We Ever Get Rid of C. Diff? - 3 year(s) ago

    C. diff infection is an old enemy and health care professionals have gathered an armamentarium of weapons against it, but it can be relentless.

    Source: Infection Control Today
    Categories: Future of Medicine, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of PulmonaryApps
      PulmonaryApps

      C. diff infection is an old enemy and health care professionals have gathered an armamentarium of weapons against it, but it can be relentless via @ICT_magazine https://t.co/1vBtgDOdLi #Cdiff #HAIs #hospitalizations #krystalklear #pulmonaryapps https://t.co/nznON9xPEO

  • Mashup Score: 186
    Myocarditis With COVID-19 mRNA Vaccines - 3 year(s) ago

    Biykem Bozkurt, Ishan Kamat and Peter J. HotezAbstract Myocarditis has been recognized as a rare complication of coronavirus disease 2019 (COVID-19) mRNA vaccinations, especially in young adult and adolescent males. According to the US Centers for Disease Control and Prevention, myocarditis/pericarditis rates are ≈12.6 cases per million doses of second-dose mRNA vaccine among individuals 12 to…

    Source: www.ahajournals.org
    Categories: Cardiologists, Latest Headlines
    Tweet Tweets with this article
    • Profile photo of NHLBI_Translate
      NHLBI_Translate

      Chart shows potential risk of #myocarditis with #COVID19 mRNA #vaccination in the 120 days after vaccination & predicted #prevention of #COVID_19 cases, #hospitalizations, ICU admissions, and #deaths according to age groups and sex. #VaccinesWork https://t.co/bPEH6oawwG #NIH_CEAL https://t.co/FmxsYAyy8u

    • Profile photo of NHLBI_Translate
      NHLBI_Translate

      .@AHAScience: Drs. Bozkurt, Kamat, and Hotez address #myocarditis with #COVID19 #Vaccines. Chart shows predicted benefits of reduction in #COVID_19–related hospitalizations, death, risks of myocarditis after 2nd dose of mRNA vaccine by age group. https://t.co/bPEH6oawwG #NIH_CEAL https://t.co/jPAzv6Qcw7

  • Mashup Score: 0
    Review shows 'urgent need' for high-quality, prospective studies on gout care strategies - 3 year(s) ago

    There is a lack of high-quality treatment studies in patients hospitalized for gout flares, and zero prospective studies on ways to improve urate-lowering therapy use and prevent readmission, according to data published in Rheumatology. “Despite effective treatments, hospitalizations for gout flares have increased dramatically, doubling in the United States between 1993 and 2011, from 4.4

    Source: www.healio.com
    Categories: Latest Headlines, Rheumatology
    Tweet Tweets with this article
    • Profile photo of HealioRheum
      HealioRheum

      “This systematic review highlights an urgent need for prospective studies of strategies to prevent #hospitalizations from #gout ...” researchers noted https://t.co/JAwFpLFSKu

Load More